News

Health insurance company Cigna (NYSE:CI) in Q1 CY2025, with sales up 14.4% year on year to $65.5 billion. Its non-GAAP profit ...
The Cigna Group is the latest multinational accused of violating its duties to its retirement plan participants by using forfeited funds to reduce employer contributions to its plan, a new proposed ...
Employees who are engaged in maintaining their well-being tend to be healthier, which leads to lower health-related business ...
The public sector has begun eyeing open platforms for edge computing to improve public safety, optimize infrastructure and ...
Explore the future of finance with open banking. Is it truly the right move for credit unions and who really benefits from it ...
Dr. Ayesha Khanna shares how artificial intelligence drives meaningful change across healthcare, finance, and crisis response ...
Cigna Saver Rx: Cigna describes this plan as ... you can switch plans during Medicare's open enrollment period, Oct. 15 to Dec. 7. Changes go into effect on the following Jan. 1.
The drug has been chosen as the sole ustekinumab by BCBSM, Florida Healthcare Plan, and other closed-door health systems.
The Cigna Group (CI) reports robust first-quarter results with significant revenue increases and an optimistic outlook for the year.
Cigna Investor Relations will be available to respond to additional questions shortly. A recording of this conference will be available for 10 business days following this call. You may access the ...
Cigna (CI) reported $65.45 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 14.3%. EPS of $6.74 for the same period compares to $6.47 a year ago.
The share repurchase program may be effected through open market purchases in compliance ... or administrative services agreement issued by Cigna Healthcare; have access to Cigna Healthcare's ...